Tiemo Bandel
- The novel elastase inhibitor BAY 85-8501 provides a new approach in the treatment of pulmonary diseasesBy Johannes Nagelschmitz, Dorina Kaufel, Schwers Stephan, Franz von Nussbaum, Volkhart Li, Martina Delbeck, Klemens Lustig, Tiemo Bandel and Henrik WatzJohannes Nagelschmitz1Global Drug Discovery, Bayer Pharma AG, Wuppertal, GermanyDorina Kaufel1Global Drug Discovery, Bayer Pharma AG, Wuppertal, GermanySchwers Stephan1Global Drug Discovery, Bayer Pharma AG, Wuppertal, GermanyFranz von Nussbaum1Global Drug Discovery, Bayer Pharma AG, Wuppertal, GermanyVolkhart Li1Global Drug Discovery, Bayer Pharma AG, Wuppertal, GermanyMartina Delbeck1Global Drug Discovery, Bayer Pharma AG, Wuppertal, GermanyKlemens Lustig1Global Drug Discovery, Bayer Pharma AG, Wuppertal, GermanyTiemo Bandel1Global Drug Discovery, Bayer Pharma AG, Wuppertal, GermanyHenrik Watz2Pulmonary Research Institute at Lung Clinic Grosshansdorf, Airway Research Center North, German Center for Lung Research, Grosshansdorf, Germany
Buying books on this site
Purchases made on this website are of electronic books only.
About the ERS books
The ERS Monograph is the quarterly book series from the European Respiratory Society. Each Monograph covers a specific area of respiratory medicine, providing in-depth reviews that give clinicians at all levels a concise, comprehensive guide to symptoms, diagnosis and treatment.
The ERS Handbooks are compact guides to broad areas of the respiratory field. Launched in 2010, the series now covers adult, paediatric and sleep respiratory medicine, includes a companion volume of self-assessment questions and features the ERS Practical Handbooks.